# GEVO, INC. (GEVO) · Edgar & Edgarette company card

> Gevo, Inc. (GEVO) grew revenue 849% in FY2025 to $161 million, operating margin -12.6% against a -3.2% median for industrial organic chemicals, equity 64.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1392380 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/GEVO) · [JSON](https://www.pops4.com/boards/company/GEVO.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $161M |
| Revenue growth, 1 year | 849.3% |
| Revenue growth per year | 287.7% |
| Operating margin | -12.6% (prior year -536.9%) |
| Net margin | -21.1% |
| Operating cash flow | −$13M |
| Capital spending | $30M |
| Free cash flow | −$44M |
| Cash | $81M |
| Long-term debt | $165M |
| Total assets | $719M |
| Total equity | $466M |
| Equity ÷ assets | 64.9% |
| Return on equity | -7.3% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -1.4 (distress zone)
- Piotroski F: 3 of 9 (middling)
- Health Harbor boat: Weathered boat · two warning signs · operating cash flow was negative; revenue is hard to predict: its 80% range is ±32%
- Cash Compass: Fast, cash not yet · growing fast, but little cash arriving so far

## Edgarette's reading

Exposure: revenue $160.6M (FY2025), total debt $164.8M. Experience: revenue up 849.3% on the year, up 287.7% a year over 4 years; operating margin -12.6%, up from -536.9%. Soundness: equity 64.9% of assets, return on equity -7.3%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $828.3M and $1.6B next year (method v4.1: its own 2-year record of growth weighed at 25% against $100M–1B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $699.6M to $1.9B. A statistical range, not company guidance. Against peers (13 filers, $50M+ revenue, industrial organic chemicals): operating margin -12.6% against a -3.2% median; growth 849.3% against -3.5%.

Range logged 2026-10-29, receipt 70d21c316ac16c0c, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 7, latest 2026-10-28 ([filing](https://www.sec.gov/Archives/edgar/data/1392380/000162828026067732/0001628280-26-067732-index.htm))

## Recent filings

- 8-K · filed 2026-10-28 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1392380/000162828026067732/0001628280-26-067732-index.htm)
- 8-K · filed 2026-08-26 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1392380/000110465926101084/0001104659-26-101084-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1392380/000162828026054462/0001628280-26-054462-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1392380/000162828026054278/0001628280-26-054278-index.htm)
- 8-K · filed 2026-07-16 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1392380/000110465926084096/0001104659-26-084096-index.htm)
- 8-K · filed 2026-07-15 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1392380/000110465926083740/0001104659-26-083740-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001392380.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1392380

## Cite

POPS4, Edgar & Edgarette: GEVO, INC. (GEVO) company card, from the company's own SEC filings, accessed 2026-10-29, https://www.pops4.com/boards/company/GEVO. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.